Literature DB >> 1452268

Mixed gonadal dysgenesis and dysgenetic male pseudohermaphroditism--a critical analysis.

M Rohatgi1, D K Gupta, P S Menon, I C Verma, M Mathur.   

Abstract

A 10 year prospective study of 14 patients with mixed gonadal dysgenesis (MGD) and six patients with dysgenetic male pseudohermaphroditism (DMP) is reported. All of them had internal mullerian structures, along with unilateral or bilateral dysgenetic testes, ambiguous external genitalia. Twelve had been brought up as male, nine of whom had a unilateral descended testis. Eight had been reared as females, as they had bilaterally undescended gonads, and ambiguous genitalia. Clinical examination, retrograde genito-urethrography and cytogenetic studies suggested the diagnosis in 16 patients, while four were diagnosed on inguino-abdominal exploration for undescended testis. This report delineates more clearly the clinical profile of these orders. All the patients reared as male were assigned the male gender following abdominal gonadectomy, retention of scrotal testis and male genitoplasty. The eight patients who were reared as females underwent bilateral salpingo-gonadectomy and female genitoplasty. This management differs from the usual recommendation that all such children should be reared as females. Ten patients (50%) had maternal history of previous abortion/stillbirth, or drug intake in the first trimester of pregnancy suggesting a role of these factors in the etiology. All cases of DMP had a 46,XY karyotype, while eight of 14 cases of MGD had mosaicism with 45X/46,XY cell lines in blood or gonadal cultures. The clinicopathological features of patients of MGD and DMP were similar. It is suggested that these two disorders represent different spectra of the same disorder. A unifying concept of etiopathogenesis is proposed.

Entities:  

Mesh:

Year:  1992        PMID: 1452268     DOI: 10.1007/bf02751566

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  16 in total

1.  "Mixed" gonadal dysgenesis: a variety of hermaphroditism.

Authors:  A R SOHVAL
Journal:  Am J Hum Genet       Date:  1963-06       Impact factor: 11.025

2.  Gonadal histology in patients with male pseudohermaphroditism and atypical gonadal dysgenesis: relation to theories of sex differentiation.

Authors:  C BERGADA; W W CLEVELAND; H W JONES; L WILKINS
Journal:  Acta Endocrinol (Copenh)       Date:  1962-08

3.  Clinical, cytogenetic & hormonal profile in extreme hypospadias with bilaterally descended testes.

Authors:  J K Iyengar; M Rohatgi; P S Menon; A R Mathews; I C Verma; S Bhargava
Journal:  Indian J Med Res       Date:  1986-06       Impact factor: 2.375

4.  Familial XY gonadal dysgenesis.

Authors:  J Chemke; R Carmichael; J M Stewart; R H Geer; A Robinson
Journal:  J Med Genet       Date:  1970-06       Impact factor: 6.318

5.  Intersex conditions masquerading as simple hypospadias.

Authors:  D Aarskog
Journal:  Birth Defects Orig Artic Ser       Date:  1971-05

6.  Male sexual differentiation in mice lacking H-Y antigen.

Authors:  A McLaren; E Simpson; K Tomonari; P Chandler; H Hogg
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

7.  Dysgenetic male pseudohermaphroditism.

Authors:  J Rajfer; G Mendelsohn; J Arnheim; R D Jeffs; P C Walsh
Journal:  J Urol       Date:  1978-04       Impact factor: 7.450

8.  Ectopic seminiferous tubules in the tunica albuginea of normal and dysgenetic testes.

Authors:  M Nistal; R Paniagua; L León; J Regadera
Journal:  Appl Pathol       Date:  1985

9.  The presence of intersexuality in patients with advanced hypospadias and undescended gonads.

Authors:  M Rohatgi; P S Menon; I C Verma; J K Iyengar
Journal:  J Urol       Date:  1987-02       Impact factor: 7.450

10.  A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes.

Authors:  J Gubbay; J Collignon; P Koopman; B Capel; A Economou; A Münsterberg; N Vivian; P Goodfellow; R Lovell-Badge
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

View more
  7 in total

1.  The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does "disorders of sexual development (DSD)" classification based on new Chicago consensus cover all sex chromosome DSD?

Authors:  Gönül Ocal; Merih Berberoğlu; Zeynep Sıklar; Hatice Ilgın Ruhi; Ajlan Tükün; Emine Camtosun; Senay Savaş Erdeve; Bülent Hacıhamdioğlu; Suat Fitöz
Journal:  Eur J Pediatr       Date:  2012-05-30       Impact factor: 3.183

2.  Presence of Turner stigmata in a case of dysgenetic male pseudohermaphroditism with 45,X/46,X+mar karyotype.

Authors:  H Hashimoto; H Maruyama; R Koshida; N Okuda; K Murayama; T Katsumi; K Watanabe; T Sato
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 3.  Ambiguous genitalia--an Indian perspective.

Authors:  D K Gupta; P S Menon
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

4.  Mixed gonadal dysgenesis with 45, X/46, XX/46, XY mosaicism.

Authors:  A Kher; S Datta; S Kanade; M Valdya; B A Bharucha
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

Review 5.  New insights into the genetic basis of infertility.

Authors:  Thejaswini Venkatesh; Padmanaban S Suresh; Rie Tsutsumi
Journal:  Appl Clin Genet       Date:  2014-12-01

6.  Long-Term Follow-Up of Patients with 46,XY Partial Gonadal Dysgenesis Reared as Males.

Authors:  Juliana Gabriel Ribeiro de Andrade; Antonia Paula Marques-de-Faria; Helena Campos Fabbri; Maricilda Palandi de Mello; Gil Guerra-Júnior; Andréa Trevas Maciel-Guerra
Journal:  Int J Endocrinol       Date:  2014-12-14       Impact factor: 3.257

7.  Screening of Y chromosome microdeletions in 46,XY partial gonadal dysgenesis and in patients with a 45,X/46,XY karyotype or its variants.

Authors:  Ana Paula dos Santos; Juliana Gabriel Ribeiro Andrade; Cristiane Santos Cruz Piveta; Juliana de Paulo; Gil Guerra; Maricilda Palandi de Mello; Andréa Trevas Maciel-Guerra
Journal:  BMC Med Genet       Date:  2013-11-05       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.